Literature DB >> 20605585

Reduced pancreatic parenchymal thickness indicates exocrine pancreatic insufficiency after pancreatoduodenectomy.

Hiroyuki Nakamura1, Yoshiaki Murakami, Kenichiro Uemura, Yasuo Hayashidani, Takeshi Sudo, Hiroki Ohge, Taijiro Sueda.   

Abstract

BACKGROUND: The aim of this study was to investigate whether perioperative morphologic characteristics are predictive of exocrine pancreatic function after pylorus-preserving pancreatoduodenectomy (PPPD) with pancreaticogastrostomy.
MATERIALS AND METHODS: A 13C-labeled mixed triglyceride breath test was performed in 52 patients after PPPD to assess postoperative exocrine pancreatic function. A value of percent 13CO2 cumulative dose at 7 h (%CD-7 h) of less than 5% was considered diagnostic of exocrine pancreatic insufficiency. Pre- and postoperative pancreatic parenchymal thicknesses were calculated using computed tomography (CT) scans, and compared by means of receiver operating characteristic (ROC) analysis.
RESULTS: Thirty-four (65.4%) of 52 patients were found to have exocrine pancreatic insufficiency based on the breath test. With ROC analysis for identification of exocrine pancreatic insufficiency, the areas under the ROC curve for the postoperative pancreatic parenchymal thickness were higher than those for the preoperative pancreatic parenchymal thickness (0.904 and 0.702, respectively, P=0.009). When the cut-off value of the postoperative pancreatic parenchymal thickness was set at 13.0 mm, the sensitivity and specificity for identifying exocrine pancreatic insufficiency were 88.2% and 88.9%, respectively.
CONCLUSION: Reduced postoperative pancreatic parenchymal thickness is a reliable indicator of exocrine pancreatic insufficiency after PPPD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605585     DOI: 10.1016/j.jss.2010.03.052

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  13 in total

1.  Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Tokio Higaki; Masamichi Moriguchi; Nao Yoshida; Teruyuki Miyazaki; Yoichi Teshima
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

Review 2.  Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy.

Authors:  Adarsh Chaudhary; J Enrique Domínguez-Muñoz; Peter Layer; Markus M Lerch
Journal:  Dig Dis       Date:  2019-08-16       Impact factor: 2.404

Review 3.  Pathophysiology after pancreaticoduodenectomy.

Authors:  Chang Moo Kang; Jin Ho Lee
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

4.  Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C-labeled mixed triglyceride breath test.

Authors:  Seiko Hirono; Yoshiaki Murakami; Masaji Tani; Manabu Kawai; Ken-ichi Okada; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Naoya Nakagawa; Naru Kondo; Hiroki Yamaue
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

5.  Assessment of Exocrine Function of Pancreas Following Pancreaticoduodenectomy.

Authors:  Kiran Thogari; Mallika Tewari; S K Shukla; S P Mishra; H S Shukla
Journal:  Indian J Surg Oncol       Date:  2019-03-18

6.  Predicting exocrine insufficiency following pancreatic resection.

Authors:  Jonathan C King; O Joe Hines
Journal:  J Surg Res       Date:  2010-09-09       Impact factor: 2.192

7.  Impact of the transection plan on postoperative pancreatic fistulas occurring after robot-assisted distal pancreatectomy for nonmalignant pancreatic neoplasms.

Authors:  Lihan Qian; Binwei Hu; Jiancheng Wang; Xiongxiong Lu; Xiaxing Deng; Weimin Chai; Zhiwei Xu; Weishen Wang; Baiyong Shen
Journal:  Surg Endosc       Date:  2022-08-08       Impact factor: 3.453

8.  Clinical impact of atrophic changes in remnant pancreas on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Kensuke Yamamura; Yo-Ichi Yamashita; Takanobu Yamao; Yuki Kitano; Kota Arima; Tatsunori Miyata; Takaaki Higashi; Hiromitsu Hayashi; Toru Beppu; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2022-02-12

9.  Prospective observational study of prevalence, assessment and treatment of pancreatic exocrine insufficiency in patients with inoperable pancreatic malignancy (PANcreatic cancer Dietary Assessment (PanDA): a study protocol.

Authors:  Lindsay E Carnie; Angela Lamarca; Kate Vaughan; Zainul Abedin Kapacee; Lynne McCallum; Alison Backen; Jorge Barriuso; Mairéad G McNamara; Richard A Hubner; Marc Abraham; Juan W Valle
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

10.  Russian Consensus on Exo- and Endocrine Pancreatic Insufficiency After Surgical Treatment.

Authors:  Igor E Khatkov; Igor V Maev; Sayyar R Abdulkhalov; Sergey A Alekseenko; Ruslan B Allikhanov; Igor G Bakulin; Natalia V Bakulina; Andrey U Baranovskiy; Ekaterina V Beloborodova; Elena A Belousova; Sergey E Voskanyan; Lyudmila V Vinokurova; Vladimir B Grinevich; Vladimir V Darvin; Elena A Dubtsova; Tatiana G Dyuzheva; Vyacheslav I Egorov; Mikhail G Efanov; Roman E Izrailov; Vyacheslav L Korobka; Bogdan N Kotiv; Nikolay Yu Kokhanenko; Yury A Kucheryavy; Maria A Livzan; Vladimir K Lyadov; Karine A Nikolskaya; Marina F Osipenko; Victor D Pasechnikov; Ekaterina Yu Plotnikova; Oleg A Sablin; Vladimir I Simanenkov; Victor V Tsvirkun; Vladislav V Tsukanov; Alexey V Shabunin; Dmitry S Bordin; Professional Medical Society Pancreatic Club Russia
Journal:  Turk J Gastroenterol       Date:  2021-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.